RO 3306,
RO-3306,
RO3306,
Ro-3306,
872573-93-8,
RO 3306,
CHEMBL393929,
Cdk1 Inhibitor IV, RO-3306,
5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone,
C18H13N3OS2,
(5Z)-5-(quinolin-6-ylmethylidene)-2-[(thiophen-2-ylmethyl)amino]-1,3-thiazol-4(5H)-one,
ro-306,
SCHEMBL4874056,
AOB2010,
EX-A575,
XOLMRFUGOINFDQ-YBEGLDIGSA-N,
BDBM181049,
HMS3229B19,
4010AH,
BDBM50205472,
MFCD17392573,
s7747,
ZINC28821265,
AKOS024458017,
CS-3790,
(Z)-5-(quinolin-6-ylmethylene)-2-(thiophen-2-ylmethylamino)thiazol-4(5H)-one,
BC638665,
HY-12529,
R0201,
RO-3306, >=98% (HPLC),
BRD-K78373679-001-01-1,
(Z)-5-(Quinolin-6-ylmethylene)-2-[(thiophen-2-ylmethyl)amino]thiazol-4(5H)-one,
2-[(thiophen-2-ylmethyl)-amino]-5-[1-quinolin-6-yl-meth-(z)-ylidene]-thiazol-4-one,
2-[[Thiophen-2-yl)methyl]amino]-5-[1-(quinolin-6-yl)meth-(Z)-ylidene]thiazol-4-one,
(5Z)-5-[(quinolin-6-yl)methylidene]-2-{[(thiophen-2-yl)methyl]amino}-4,5-dihydro-1,3-thiazol-4-one,
CHEMBL261644,
RO3306,
CID11631681,
A8885,
C512984,
(5Z)-5-(quinolin-6-ylmethylidene)-2-(thiophen-2-ylmethylamino)-1,3-thiazol-4-one,
NR9,